Prescription drug · ANDA
Lorazepam NDC 71610-655
Lorazepam 2 mg/1 · Tablet · Oral · Aphena Pharma Solutions - Tennessee, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71610-655-15 | 71610065515 | 15 TABLET in 1 BOTTLE, PLASTIC (71610-655-15)Marketed from Nov 23, 2022 | |
| 71610-655-30 | 71610065530 | 30 TABLET in 1 BOTTLE, PLASTIC (71610-655-30)Marketed from Aug 1, 2022 | |
| 71610-655-45 | 71610065545 | 45 TABLET in 1 BOTTLE, PLASTIC (71610-655-45)Marketed from Nov 23, 2022 | |
| 71610-655-53 | 71610065553 | 60 TABLET in 1 BOTTLE, PLASTIC (71610-655-53)Marketed from Aug 1, 2022 | |
| 71610-655-60 | 71610065560 | 90 TABLET in 1 BOTTLE, PLASTIC (71610-655-60)Marketed from Aug 1, 2022 | |
| 71610-655-70 | 71610065570 | 120 TABLET in 1 BOTTLE, PLASTIC (71610-655-70)Marketed from Aug 1, 2022 | |
| 71610-655-80 | 71610065580 | 180 TABLET in 1 BOTTLE, PLASTIC (71610-655-80)Marketed from Nov 23, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Lorazepam
- Generic name (nonproprietary)
- lorazepam
- Active ingredients
- Lorazepam — 2 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 072928
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Benzodiazepines (Chemical structure)
- Identifiers
- Product ID 71610-655_e064bed4-48cf-4fac-b5f4-c62a4634984aSPL ID e064bed4-48cf-4fac-b5f4-c62a4634984aSPL set ID 3c20c89f-c8c3-43b3-837e-da413f449795RxCUI 197900, 197901, 197902UNII O26FZP769L
- Pharmacologic class
- Benzodiazepine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471610065515followed by a unit qualifier and the quantityPackage 71610-0655-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS AND USAGE Lorazepam tablets are indicated for the management of anxiety disorders or for the short-term relief of the symptoms of anxiety or anxiety associated with depressive symptoms. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The effectiveness of lorazepam in long-term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should periodically reassess the usefulness of the drug for the individual patient.
Excerpt only. Read the full label for complete information.
About NDC 71610-655
- What is NDC 71610-655?
- 71610-655 is the product NDC for Lorazepam, Lorazepam 2 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 7 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Lorazepam.
- What is the active ingredient?
- Lorazepam.
- Who is the labeler?
- Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Lorazepam?
- 135 other product NDCs are listed under this name. See all Lorazepam NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Lorazepam products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-091 | 87441-0091-01 |
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-4180 | 68788-4180-0168788-4180-0368788-4180-06+2 more |
| Lorazepam | Lorazepam .5 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-947 | 60760-0947-02 |
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | St. Mary's Medical Park Pharmacy | 60760-948 | 60760-0948-02 |
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-051 | 87441-0051-01 |
| Lorazepam | Lorazepam .5 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-050 | 87441-0050-01 |
| Lorazepam | Lorazepam 1 mg/1 | TabletOral | Coupler LLC | 67046-0230 | 67046-0230-03 |
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | Coupler LLC | 67046-0936 | 67046-0936-03 |
| Lorazepam | Lorazepam .5 mg/1 | TabletOral | Coupler LLC | 67046-0786 | 67046-0786-03 |
| Lorazepam | Lorazepam 2 mg/mL | LiquidOral | American Health Packaging | 68000-107 | 68000-0107-05 |
Other NDCs under ANDA 072928
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | Golden State Medical Supply, Inc. | 51407-998 |
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | Unit Dose Solutions, Inc. | 87441-051 |
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-3188 |
| Lorazepam | Lorazepam 2 mg/1 | TabletOral | Teva Pharmaceuticals USA, Inc. | 0093-3427 |